Women’s Health Report Assesses first-in-class innovation with focus on endometriosis, polycystic ovarian syndrome and cervical intraepithelial neoplasia

This report assesses first-in-class innovation across the women’s health therapy area, with a particular focus on three key indications: endometriosis, polycystic ovarian syndrome (PCOS) and cervical intraepithelial neoplasia (CIN).

Pune, India - March 14, 2018 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population. Despite this, the women’s health market is relatively small. This reflects diagnostic barriers and high levels of non-treatment for women’s health disorders, as well as high levels of genericization and relatively limited innovation within recent decades.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline
• Many women’s health disorders are highly prevalent. How do epidemiology trends vary for endometriosis, PCOS and CIN?
• Innovation within women’s health has been relatively limited over recent decades. What are the most prominent unmet needs across this therapy area?
• There are 261 pipeline programs in active development for women’s health. What proportion of these products are first-in-class? How does first-in-class innovation vary by indication, development stage and molecular target class?
• Although the first-in-class pipeline is relatively modest in size it is considerably diverse with eight distinct molecular target classes represented. Which first-in-class targets have been identified as most promising for women’s health conditions?
• Over 200 licensing deals relating to women’s health have been completed since 2006. Do women’s health products typically attract high deal values? Which first-in-class products have prior deal involvement?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/987871
Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of symptoms, epidemiology, etiology, pathophysiology, co-morbidities and complications, diagnosis and treatment options.
• Visualize the composition of the women’s health market in terms of dominant molecule types and molecular targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
• Analyze the women’s health pipeline and stratify by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising first-in-class targets have been reviewed in greater detail.
• Recognize commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals, and identifying women’s health therapies that have not yet been involved in deals and may offer potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/987871

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/womens-health-report-assesses-first-in-class-innovation-with-focus-on-endometriosis-polycystic-ovarian-syndrome-and-cervical-intraepithelial-neoplasia/314337

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline%20%20

Source: MarketersMedia

Release ID: 314337

More Press Releases

World markets roiled by rising fears of US-China trade war

Mar 23, 2018

HONG KONG — Fears of a trade war roiled financial markets and sent the dollar wobbling Friday after Beijing retaliated against the Trump administration's tariff hikes by threatening import duties on U.S. goods. Stocks plunged on Wall Street after U.S. President Donald Trump imposed sanctions Thursday on goods and investment from China. The Dow Jones industrial average dropped more than 700 points as investors feared trade tensions between the world's largest economies would escalate. That fear rippled into Europe. In early trading, Germany's DAX slid 1.3 percent to 11,941.68, France's CAC 40 lost 1.3 percent to 5,101.63 and Britain's FTSE...

China may hike tariffs on US pork, aluminum, other goods

Mar 23, 2018

BEIJING — China announced a $3 billion list of U.S. goods including pork, apples and steel pipe on Friday that it said may be hit with higher tariffs in a spiraling trade dispute with President Donald Trump that companies and investors worry could depress global commerce. The Commerce Ministry urged Washington to negotiate a prompt settlement to the conflict over Trump's tariff hike on steel and aluminum but set no deadline. Separately, the ministry also criticized Trump's decision to approve a possible tariff hike on billions of dollars of Chinese goods in a dispute over Beijing's technology policy. The ministry...

Asian shares slump on fears of trade war between US, China

Mar 23, 2018

HONG KONG — Asian stock markets slumped Friday after Beijing responded to the Trump administration's tariff hikes by saying it may order higher import duties on a range of U.S. goods, ratcheting up fears of a trade war. Stocks plunged Thursday on Wall Street after U.S. President Donald Trump imposed sanctions on goods and investment from China. The Dow Jones industrial average dropped more than 700 points as investors feared that trade tensions between the world's largest economies would escalate. The planned sanctions include tariffs on $48 billion worth of Chinese imports as well as restrictions on Chinese investments. Trump...

Venezuela president solution to inflation: Change money

Mar 23, 2018

CARACAS, Venezuela — President Nicolas Maduro attempted to tackle Venezuela's staggering inflation Thursday by lopping three zeros off the increasingly worthless currency called the bolivar. New bills replacing those like the current 100,000 note — worth less than 50 U.S. cents on the commonly used black market — should begin circulating June 4, he said. The move comes as Venezuelans struggle to find food, medicine and cash in the worst economic crisis ever to strike the oil-rich country. "Let's defend our bolivar!" Maduro said in a state television broadcast. He said the "redenomination" will relieve the cash shortages. Venezuela holds...

As US gets tough with China, Wall Street gets weak-kneed

Mar 23, 2018

NEW YORK — The prospect of a full-blown trade war between the world's two biggest economies rattled investors Thursday, sending stocks to their biggest loss in six weeks. The Dow Jones industrial average plunged more than 700 points, as President Donald Trump announced plans to slap tariffs on Chinese imports. The Chinese government vowed to defend itself. Investors worried that if the dispute escalated, China will counterpunch with restrictions of its own, hurting American exports of airplanes, construction equipment and other goods. It didn't take long for China to threaten to hit back. The Commerce Ministry announced a list of...

Subscribe to our newsletter!

Your Name

Your Email Address